Abstract |
Amyloidosis refers to a group of degenerative diseases that are characterized by the deposition of misfolded protein fibrils in various organs. Deposited amyloid may be removed by a phagocyte-dependent innate immune system; however, the precise mechanisms during disease progression remain unclear. We herein investigated the properties of macrophages that contribute to amyloid degradation and disease progression using inducible apolipoprotein A-II amyloidosis model mice. Intravenously injected AApoAII amyloid was efficiently engulfed by reticuloendothelial macrophages in the liver and spleen and disappeared by 24 h. While cultured murine macrophages degraded AApoAII via the endosomal-lysosomal pathway, AApoAII fibrils reduced cell viability and phagocytic capacity. Furthermore, the depletion of reticuloendothelial macrophages before the induction of AApoAII markedly increased hepatic and splenic AApoAII deposition. These results highlight the physiological role of reticuloendothelial macrophages in the early stages of pathogenesis and suggest the maintenance of phagocytic integrity as a therapeutic strategy to inhibit disease progression.
|
Authors | Hiroki Miyahara, Jian Dai, Ying Li, Xiaoran Cui, Hibiki Takeuchi, Naomi Hachiya, Fuyuki Kametani, Masahide Yazaki, Masayuki Mori, Keiichi Higuchi |
Journal | Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
(Amyloid)
Vol. 30
Issue 2
Pg. 225-238
(Jun 2023)
ISSN: 1744-2818 [Electronic] England |
PMID | 36495239
(Publication Type: Journal Article)
|
Chemical References |
- Apolipoprotein A-II
- Amyloid
- Amyloidogenic Proteins
|
Topics |
- Mice
- Animals
- Apolipoprotein A-II
(metabolism)
- Amyloidosis
(metabolism)
- Amyloid
(metabolism)
- Mononuclear Phagocyte System
(metabolism, pathology)
- Macrophages
(metabolism)
- Amyloidogenic Proteins
- Disease Progression
|